openPR Logo
Press release

Oran Diagnostics Adds Reproductive Health to License Agreement with Carmel Diagnostics

02-17-2011 05:15 PM CET | Health & Medicine

Press release from: LearnWell

BERWYN, PA, February 14, 2011. Oran Diagnostics, LLC, a privately held diagnostics company, today announced that it has expanded its exclusive worldwide license agreement with Carmel Diagnostics, Ltd. of Kiryat Tivon, Israel, to include reproductive health. This expansion into reproductive medicine enables Oran to continue development of TCL-EV™, a rapid, non-invasive procedure that can be used to identify embryos with the greatest reproductive potential in patients undergoing IVF. TCL-EV™ is designed to enhance IVF outcomes and potentially reduce the frequency of multiple gestations. The TCL-EV ™ assay is based on the TCL-Analyzer, a platform technology developed by Carmel Diagnostics that measures oxidative stress and oxidizability in biologic samples using the proprietary method of thermochemiluminescence (TCL).

Bruce Goldstein, President and CEO of Oran Diagnostics, commented, “Oran’s objective is to provide IVF practitioners an objective method for viable embryo selection that will allow them to reduce the number of embryos transferred while increasing pregnancy rates. The unmet need for such an assay is enormous.” As recently shown in a study published in Fertility and Sterility, the TCL profile of an embryo is associated with the chances of successful outcome, and TCL-EV™ may serve as a useful tool for improving embryo selection in IVF. Oran is commencing a multi-center, multi-national validation study of TCL-EV™ to further support the development and commercialization of TCL-EV™.

Oran also continues to develop TCL-HF™, a rapid, accurate, and inexpensive prognostic marker that aids in assessing disease severity in patients diagnosed with heart failure and allows the clinician to intervene earlier and modify treatment to meet an individual patient’s therapeutic needs. Pipeline products include assays to diagnose and monitor neurologic and neurodegenerative diseases.

About Oran Diagnostics: The Company’s mission is to be the market leader in providing minimally invasive technologies that measure oxidative stress as a valid and clinically relevant marker of disease and disease severity to hospitals, clinics and medical practitioners to improve patient care while reducing cost.

Bruce Goldstein
Oran Diagnostics, LLC
61 Cassatt Avenue
Berwyn, PA 19312

Phone: (888) 556-6726
Email: bgoldstein [at] orandx [dot] com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oran Diagnostics Adds Reproductive Health to License Agreement with Carmel Diagnostics here

News-ID: 162983 • Views: 1181

More Releases from LearnWell

Bill Ringle Interviews Business Sales Expert Mark Satterfield on My Quest for Be …
Bill Ringle, America’s Business Growth Strategist, talked with Mark Satterfield, CEO of Gentle Rain Marketing, for the interview show My Quest for the Best. Philadelphia, PA, May 06, 2012 - Business growth strategist Bill Ringle interviewed Mark Satterfield, CEO of Gentle Rain Marketing and author of Unique Sales Stories, for My Quest for the Best. In this interview series, Ringle speaks with successful industry experts and outstanding business leaders about their
Greater Philadelphia Business Owners Gather to Find Out How to “Become Famous …
Philadelphia, PA - January 14, 2011 - On January 11, 2011, Bill Ringle, founder of Rainmaker Academy, partnered with the Baiada Center at Drexel University to lead a half-day session titled “Become Famous In Your Niche so Business Comes to You”. Ringle led a full room of entrepreneurs and business owners through tips, insights and practical lessons in business development and marketing. While navigating topics such as defining your
Todd Wallach and Paul Sohmer, MD join Oran Diagnostics’ Board of Managers
BERWYN, PA, October 1, 2010—Oran Diagnostics, LLC, a specialized medical device company developing novel clinical diagnostic tools for applications across a broad spectrum of disease states, today announced that Todd Wallach and Paul Sohmer, MD have joined the Company’s Board of Managers. Mr. Wallach is the Chairman and Chief Executive Officer of Molecular Detection, Inc. (MDI). MDI is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready™ molecular diagnostic tests for the
Oran Diagnostics Announces Appointments to Scientific Advisory Board
BERWYN, PA, October 12, 2010—Oran Diagnostics, LLC, a specialized medical device company developing novel clinical diagnostic tools for applications across a broad spectrum of disease states, today announced that it has finalized the composition of its scientific advisory board with the addition of two new members. Comprised of world-renowned cardiologists and scientists, the advisory board will play an important role in guiding and participating in Oran’s research and clinical development

All 5 Releases


More Releases for TCL

Global 40 Inch TVs Market 2019 - VIZIO, Sony, TCL, Samsung
The new market research study on Global 40 Inch TVs Market in-depth market analysis with specific segments such as application, regional markets, end-users, policy analysis, value chain structure, and emerging trends. The 40 Inch TVs market report makes a case for investments in particular regions based on a realistic view of their regulatory environment, manufacturing dynamics and availability of skills and resources.The report’s analysis is based on technical data and
Data Centre Market Overview: Thriving Worldwide with (TCL, Cisco, IBM)
A new research document is added in HTF MI database of 54 pages, titled as 'UK Data Centre Trends' with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, UK, Europe or Asia and important players/vendors such as TCL, Digital Realty Trust, Inc. IBM Corporation, Hitachi Ltd., Cisco System, Inc., Hewlett-Packard Inc., EMC Corporation, and CyrusOne. The report will help
Global LCD Display Market 2018 - InnoLux, AUO, BOE, TCL, Sharp
Apex Market Research, recently published a detailed market research study focused on the "LCD Display Market" across the global, regional and country level. The report provides 360° analysis of "LCD Display Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global LCD Display industry, and estimates the future trend of LCD Display market
Global Ultra-HD TV Market 2018 - Hisense, LG, Vizio, TCL
Apex Market Research, recently published a detailed market research study focused on the "Ultra-HD TV Market" across the global, regional and country level. The report provides 360° analysis of "Ultra-HD TV Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Ultra-HD TV industry, and estimates the future trend of Ultra-HD TV market
TCL Associates Takes Short Term Position in Gamestop
TCL Associates has identified Gamestop, a video game retailer, as having major upcoming catalyst that will drive the stock higher. Microsoft and Sony will be competing as they release new consoles, but whoever win Gamestop will profit. Gamestop has endured more than two years without many new video game platforms on older platforms, but now the retailer is about to have a slurry of catalysts that will drive the stock higher.
TCL Associates Reports Quarter Two Financial Results
TCL Associates a Tokyo based equity researcher published its second quarter financial results on Wednesday. Retail had a solid quarter on the back of a strong Japanese market and asset management had its best quarter since 2007. Aug. 08, 2013 - CHUO-KU, Japan -- TCL Associates on Wednesday announced its consolidated financial results for the second quarter of the calendar year ending December 31st 2013. Net revenue in the second quarter